COCP - CIK 0001412486
The table below shows Cocrystal Pharma, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.03M | $9.86M | $26.35M | $37.22M | $58.70M | $33.01M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | $556.00K | $556.00K |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $8.13M |
| $11.58M |
| $29.09M |
| $40.18M |
| $59.32M |
| $34.02M |
| Property, plant & equipment | $93.00K | $153.00K | $271.00K | $342.00K | $453.00K | $591.00K |
| Goodwill | - | - | $19.09M | $19.09M | $19.09M | $19.09M |
| Total assets | $9.71M | $13.46M | $31.26M | $40.84M | $79.39M | $54.24M |
| Accounts payable | $890.00K | $1.54M | $1.22M | $614.00K | $578.00K | $657.00K |
| Total current liabilities | $2.21M | $2.43M | $3.26M | $1.22M | $1.54M | $1.36M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.38M | $3.93M | $4.88M | $1.27M | $1.84M | $1.74M |
| Retained earnings | -$342.25M | -$333.42M | -$315.91M | -$297.93M | -$259.09M | -$244.91M |
| Total equity | $6.33M | $9.52M | $26.38M | $39.57M | $77.55M | $52.51M |